5 Fastest Growing Biotech Companies in the US

3. CSL Limited 

Year on Year growth: 21.14% 

CSL Limited, standing third among the fastest growing biotech companies in the US, comprises CSL Behring, CSL Seqirus, and CSL Vifor, specializing in rare diseases, influenza vaccines, and nephrology. CSL Behring leads in treating rare diseases, while CSL Seqirus focuses on influenza prevention, and CSL Vifor addresses iron deficiency and nephrology.

Recent trends include active participation in medical events, patient advisory boards to improve clinical trials, and acquisitions like Vitaeris and Vifor Pharma AG. Financially, CSL reported a revenue of US$12.7 billion in 2023. Future trends indicate growth prospects in influenza vaccines and iron deficiency treatments, supported by CSL’s focus on rare diseases and innovative therapies.